MPXO.F Stock Overview
Operates as a cannabis company in Canada and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
MPX International Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0002 |
| 52 Week High | US$0.0037 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 11 Month Change | 19,900.00% |
| 3 Month Change | 19,900.00% |
| 1 Year Change | 19,900.00% |
| 33 Year Change | -99.59% |
| 5 Year Change | -99.94% |
| Change since IPO | -99.97% |
Recent News & Updates
Recent updates
Shareholder Returns
| MPXO.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | 2.6% | 0.5% |
| 1Y | 19,900.0% | 13.1% | 30.7% |
Return vs Industry: MPXO.F exceeded the US Pharmaceuticals industry which returned 14.2% over the past year.
Return vs Market: MPXO.F exceeded the US Market which returned 32.3% over the past year.
Price Volatility
| MPXO.F volatility | |
|---|---|
| MPXO.F Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.9% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.3% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: MPXO.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine MPXO.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | n/a | William Boyes | mpxinternationalcorp.com |
MPX International Corporation, operates as a cannabis company in Canada and internationally. It offers cannabis products under HOLYWEED, beleaf, SALSUS, MPX labs, Canveda, SPARTAN WELLNESS, HIGH12, STRAIN REE, PENNIES, Kingsway, DAIZE, and alice brands. The company was founded in 2015 and is headquartered in Toronto, Canada.
MPX International Corporation Fundamentals Summary
| MPXO.F fundamental statistics | |
|---|---|
| Market cap | US$28.86k |
| Earnings (TTM) | -US$20.23m |
| Revenue (TTM) | US$4.77m |
0.0x
P/S Ratio0.0x
P/E RatioIs MPXO.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MPXO.F income statement (TTM) | |
|---|---|
| Revenue | CA$6.69m |
| Cost of Revenue | CA$3.37m |
| Gross Profit | CA$3.33m |
| Other Expenses | CA$31.68m |
| Earnings | -CA$28.36m |
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did MPXO.F perform over the long term?
See historical performance and comparison